Pharma

Pharma may be an abbreviation for:

ǁ

 

When Pharma directors vote for regulations and are on the board of the legacy media and become billionaires and can purchase legacy media, Pharma is no longer subject to regulations, but writes the regulations and issues orders to impose false medications.  

Eventually, indirectly, Pharma imposes state of siege and brings about sanitary fascism, complete with censorship, but with the added power of controlling our bodies.

Thus the First Amendment is vacated and Habeas Corpus is voided.

After regulatory capture, Pharma is no longer subject to laws and regulations.  

We are subject to Pharma regulations and must obey Pharma decrees.

An investigation by ProPublica found that at least 21 doctors have been paid more than $500,000 for speeches and consulting by drugs manufacturers since 2009, with half of the top earners working in psychiatry, and about $2 billion in total paid to doctors for such services. AstraZeneca, Johnson & Johnson and Eli Lilly have paid billions of dollars in federal settlements over allegations that they paid doctors to promote drugs for unapproved uses. Some prominent medical schools have since tightened rules on faculty acceptance of such payments by drug companies.[136]

In contrast to this viewpoint, an article and associated editorial in the New England Journal of Medicine in May 2015 emphasized the importance of pharmaceutical industry-physician interactions for the development of novel treatments, and argued that moral outrage over industry malfeasance had unjustifiably led many to overemphasize the problems created by financial conflicts of interest. The article noted that major healthcare organizations such as National Center for Advancing Translational Sciences of the National Institutes of Health, the President's Council of Advisors on Science and Technology, the World Economic Forum, the Gates Foundation, the Wellcome Trust, and the Food and Drug Administration had encouraged greater interactions between physicians and industry in order to bring greater benefits to patients.[137][138]

ǁ

Here we have Wikipedia's brief iteration of semi-contrite Pharma corruption, followed by a slippery NEJM editorial.  

Funny, they list all major criminal groups in charge of the current vaccinal fraud.  What will they not do to bring "greater benefit to patients"!

Response to COVID-19[edit]

In November 2020 several pharmaceutical companies announced successful trials of COVID-19 vaccines, with efficacy of 90 to 95% in preventing infection. Per company announcements and data reviewed by external analysts, these vaccines are priced at $3 to $37 per dose.[139] The Wall Street Journal ran an editorial calling for this achievement to be recognized with a Nobel Peace Prize.[140]

 

ǁ

We are entering here into the involuntary satire department.  

Nobel Prize to be shared by Pfizer's Bourla and by the Nine 2020 Vaccinal Billionaires.   As well deserved as the Nobel Peace Prize for Henry Kissinger and Brak Obama

American pharmaceutical company Gilead sought and obtained orphan drug status for remdesivir from the US Food and Drug Administration (FDA) on 23 March 2020. 

American pharmaceutical company Gilead sought and obtained orphan drug status for remdesivir from the US Food and Drug Administration (FDA) on 23 March 2020. This provision is intended to encourage the development of drugs affecting fewer than 200,000 Americans by granting strengthened and extended legal monopoly rights to the manufacturer, along with waivers on taxes and government fees.[145][146] Remdesivir is a candidate for treating COVID-19; at the time the status was granted, fewer than 200,000 Americans had COVID-19, but numbers were climbing rapidly as the COVID-19 pandemic reached the US, and crossing the threshold soon was considered inevitable.[145][146] Remdesivir was developed by Gilead with over $79 million in U.S. government funding.[146] In May 2020, Gilead announced that it would provide the first 940,000 doses of remdesivir to the federal government free of charge.[147] After facing strong public reactions, Gilead gave up the "orphan drug" status for remdesivir on 25 March.[148] Gilead retains 20-year remdesivir patents in more than 70 countries.[141]

ǁ

A very deadly orphan indeed!

Charitable programs[edit]

In 2011 four of the top 20 corporate charitable donations and eight of the top 30 corporate charitable donations came from pharmaceutical manufacturers. The bulk of corporate charitable donations (69% as of 2012) comes by way of non-cash charitable donations, the majority of which again were donations contributed by pharmaceutical companies.[155]

Charitable programs and drug discovery & development efforts by pharmaceutical companies include:

ǁ

Strategies Against River Blindness

For many years, river blindness could be prevented by putting larvicides in streams to kill the fly larvae and control the black fly populations. The process is expensive, environmentally risky, and difficult to implement. The only medicines available had serious toxicities and could only be administered intravenously. In the 1980s, the pharmaceutical company Merck & Co., Inc., demonstrated that annual treatment with the orally administered microfilaricidal drug, ivermectin (Mectizan®), could not only help relieve the unpleasant symptoms from the skin disease but could also improve vision and prevent blindness. In 1987, Merck announced that it would donate Mectizan, to all who needed it, for as long as needed.
https://web.archive.org/web/20060826235817/http://www.cartercenter.org/healthprograms/showdoc.asp?programID=2&submenu=healthprograms

Yes, that was very nice, and they got tax deductions and good feelings from it.

 

View Comments